by Editorial | Apr 28, 2020 | 2020 News, Contract Pharma
Genalyte Inc. has made available its rapid COVID-19 serology panel on its Maverick platform. The panel tests for the detection of IgG and IgM antibodies that the body produces in response to the novel coronavirus (SARS-CoV-2). READ MORE
by Editorial | Apr 27, 2020 | 2020 News, Bio World
San Diego-based Genalyte Inc. said its rapid COVID-19 serology panel is now available on its Maverick platform. The test detects IgG and IgM antibodies to the novel coronavirus, SARS-CoV-2. READ MORE
by Editorial | Apr 27, 2020 | 2020 News, SD Metro
Genalyte, a next-generation lab service company focused on decentralizing diagnostic testing, has acquired BaseHealth, a Bay Area health care data analytics company. The combined company will provide onsite, rapid diagnostics with data analytics capabilities to enable...
by Editorial | Apr 27, 2020 | 2020 News, RT Magazine
Genalyte has released its rapid SARS-CoV-2 Multi-Antigen Serology Panel, a COVID-19 diagnostic that can detect antibodies in patients who have had the virus. The diagnostic is run on Genalyte’s Maverick platform. The panel tests for the detection of IgG and...
by Editorial | Apr 27, 2020 | 2020 News
First Instrument-Based, Rapid Test Uses Multi-Antigen Approach to Achieve Best-in-Class Sensitivity and Specificity, U.S. FDA EUA Submitted SAN DIEGO, April 27, 2020 /PRNewswire/ — Genalyte, the company empowering physicians and patients with...
Recent Comments